vimarsana.com

Primary Data Readout On Track News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Operational

Ebvallo™ EU Launch Activities Led by Pierre Fabre to Commence in Q1 2023Discussions with FDA Progressing on Potential U.S. BLA for Tab-cel®ATA188 Phase 2 EMBOLD Study Primary Data Readout On-Track for October 2023Cash Runway Extended into Q2 2024THOUSAND OAKS, Calif. (BUSINESS WIRE) $ATRA #CART Atara Biotherapeut.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.